ASH 2024: HARMONY Alliance activities at the 66th Annual Meeting of the American Society of Hematology

#bigdataforbloodcancer, AML, MM, Other events, Research

HARMONY Alliance experts will participate and present in different forums in the framework of the 66th Annual Meeting of the American Society of Hematology

Saturday 7th

ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
- Time: 4:00 p.m. - 5:30 p.m.
- Place: Marriott Marquis San Diego Marina, Pacific Ballroom Salons 24-26
- Link to the speakers and full content of the session

This 90-minute special-interest session will focus on the ASH Research Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the ASH Research Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real-world data registries.

Poster presentation: Development and Validation of Novel Machine Learning-Based Risk Scores for Multiple Myeloma: Insights from the Harmony Alliance Big Data Platform by Adrian Mosquera
- Time: 5:30 PM-7:30 PM
- Place: Halls G-H San Diego Convention Center
- Link to the abstract: https://ash.confex.com/ash/2024/webprogram/Paper201448.html

Sunday 8th

HARMONY Alliance Session at ELN Breakfast Meeting
- Time: 6:00 a.m. - 10:00 a.m.
- Place: Liberty Station Conference Center

Link to the full program of the HARMONY Alliance Session

Monday 9th

HARMONY Alliance collaborators will be presenting scientific results in two oral presentations.

Oral presentation: Early Relapse in Patients with Newly-Diagnosed Multiple Myeloma: A European Myeloma Network/Harmony Alliance Analysis Including 10843 Patients by Elias K. Mai, Heidelberg University Hospital, Germany
- Time and Location:
  Monday, December 9, 2024: 2:45 PM-4:15 PM
  Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Session: 653. Multiple Myeloma: Clinical and Epidemiological: Exploring T Cell Redirecting Therapies, Mutation Profiles and Early Relapse
- Link to the abstract: https://ash.confex.com/ash/2024/webprogram/Paper193310.html
Oral presentation: The Prognostic Impact of Myelodysplasia-Related Gene Mutations in Acute Myeloid Leukemia with FLT3-ITD Mutations by Rabea Mecklenbrauck, Hannover Medical School, Germany
- Time and Location:
  Monday, December 9, 2024: 2:45 PM-4:15PM
  Grand Hall C (Manchester Grand Hyatt San Diego)
- Session: 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Genetic Markers and Outcomes in AML
  Hematology Disease Topics & Pathways
- Link to the abstract: https://ash.confex.com/ash/2024/webprogram/Paper202362.html

Link to the annual meeting website >

Receive the latest news. Click here to subscribe!

Public-private partnership for Big Data in Hematology

HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).